I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed. Chris Stern
Friday, August 26, 2011 BiopharmaWatch Research 1 min read
Key Takeaway: I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~24 mo
Minimal dilution risk
Lead asset
Levosimendan
Phase 3 · Coronary Artery Bypass Grafting
Full Press Release Details
I am very surprised at this. I don't agree and do not accept my termination, and I request this filing be stopped until the attorneys have talked. And then it needs to be changed.